Associated Banc-Corp (ASB)
NYSE: ASB · Real-Time Price · USD
24.09
-0.65 (-2.63%)
Aug 1, 2025, 4:00 PM - Market closed

Verve Therapeutics Revenue

Associated Banc-Corp had revenue of $348.98M in the quarter ending June 30, 2025, with 16.82% growth. This brings the company's revenue in the last twelve months to $1.04B, up 3.82% year-over-year. In the year 2024, Associated Banc-Corp had annual revenue of $952.86M, down -6.56%.

Revenue (ttm)
$1.04B
Revenue Growth
+3.82%
P/S Ratio
3.71
Revenue / Employee
$258,991
Employees
4,000
Market Cap
3.94B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024952.86M-66.88M-6.56%
Dec 31, 20231.02B-186.96M-15.49%
Dec 31, 20221.21B60.46M5.27%
Dec 31, 20211.15B25.52M2.28%
Dec 31, 20201.12B-79.85M-6.65%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.